Drug Type Small molecule drug |
Synonyms Atorvastatin/dalcetrapib |
Mechanism CETP inhibitors(Cholesteryl ester transfer protein inhibitors), HDL-cholesterol stimulants, HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC66H76CaF2N4O13 |
InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N |
CAS Registry344423-98-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lipid Metabolism Disorders | Phase 1 | - | - | |
Lipid Metabolism Disorders | Phase 1 | NZ | - |